The minor allele of ANGPTL8 rs2278426 has a protective effect against CAD in T2DM patients
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Istanbul Üniversitesi
- Istanbul University Scientific Research Projects Unit (40223)
This publication has 30 references indexed in Scilit:
- Higher circulating levels of ANGPTL8 are associated with body mass index, triglycerides, and endothelial dysfunction in patients with coronary artery diseaseMolecular and Cellular Biochemistry, 2020
- Physical Exercise for Human Health2020
- High betatrophin in coronary patients protects from cardiovascular eventsAtherosclerosis, 2020
- The potential role of angiopoietin-like protein-8 in type 2 diabetes mellitus: a possibility for predictive diagnosis and targeted preventive measures?EPMA Journal, 2019
- Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiotaDiabetologia, 2018
- High frequency of type 2 diabetes and impaired glucose tolerance in Japanese subjects with the angiopoietin-like protein 8 R59W variantJournal of Clinical Lipidology, 2018
- ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipaseMolecular Metabolism, 2017
- Insulin Resistance, Obesity and Lipotoxicity2017
- Structural characterization of ANGPTL8 (betatrophin) with its interacting partner lipoprotein lipaseComputational Biology and Chemistry, 2016
- Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein familyBiochemical and Biophysical Research Communications, 2013